imperial innovations group p
(IVO:London Stock Exchange)
Transactions by IMPERIAL INNOVATIONS GROUP P (IVO) in the last 6 months
JustYoyo Ltd. announced that it has received £5.90 million in its series A round of funding led by existing investor Imperial Innovations Group plc on April 15, 2015. The transaction included participation from a number of angel investors Phillip Riese, Jonathan Weiner, Anil Aggarwal, Michael Tobin OBE, and Taavet Hinrikus. Imperial Innovations Group plc invested £5 million in the transaction, representing a stake of 15.2% in the company's issued and outstanding share ...
Cortexica Vision Systems Limited announced that it has received £2.3 million in funding from returning investor, Imperial Innovations Group plc on March 13, 2015. The company issued convertible loan in the transaction.
Apple Europe Ltd acquired Semetric Limited from Imperial Innovations Group plc (AIM:IVO) and Pentech Ventures recently. For the year ended 2013, Semetric posted loss of £1.4 million and net assets of £1.3 million. Imperial Innovations sold 27.3% stake in Semetric. Post acquisition, Semetric Limited will change its registered office.
Veryan Medical, Ltd. announced that it has received £18 million in its series B round of equity funding led by existing investor Imperial Innovations Group plc on January 14, 2015. The transaction included participation from Seven Mile Capital Partners, INVESCO Asset Management Limited, and existing investor Seroba Kernel Life Sciences Limited. Imperial Innovations Group plc invested £8.40 million in the transaction. Post the closing of the transaction, Imperial Innovations ...
INVESCO Asset Management Limited
Seroba Kernel Life Sciences Limited
Seven Mile Capital Partners
Abingdon Health Ltd acquired remaining 45% stake in Molecular Vision Limited from Imperial Innovations Group plc (AIM:IVO) and others on January 8, 2015.
Cell Medica Limited announced that it has received £50 million in series B round of funding on November 25, 2014. The transaction was led by existing investor, Imperial Innovations Group plc for £15 million and included the participation from existing investor Invesco Perpetual, Woodford Investment Management. Pursuant to the transaction, Imperial Innovations Group will hold 27.9% stake in the company. Rob Wood, Partner and Caroline Drummond, Senior Associate at Osborne ...
Woodford Investment Management LLP
|Health Discovery Corp||$0.02 USD||0.00|
|Miraculins Inc||C$0.11 CAD||0.00|
|Myriad Genetics Inc||$34.53 USD||+0.35|
|Vermillion Inc||$1.70 USD||-0.06|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|